Gain Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Gain Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Gain Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gain Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.7k | 2.7k | 1.78 |
| 2024-06-30 | $3.4k | 2.7k | 1.28 |
| 2024-03-31 | $14k | 3.8k | 3.77 |
| 2023-12-31 | $12k | 3.7k | 3.26 |
| 2023-09-30 | $12k | 3.7k | 3.27 |
| 2023-06-30 | $17k | 3.7k | 4.48 |
| 2022-12-31 | $12k | 3.7k | 3.13 |
| 2022-09-30 | $0 | 2.7k | 0.00 |
| 2022-06-30 | $10k | 2.7k | 3.77 |
| 2022-03-31 | $0 | 2.7k | 0.00 |
| 2021-12-31 | $0 | 23 | 0.00 |
| 2021-09-30 | $0 | 23 | 0.00 |
| 2021-06-30 | $0 | 24 | 0.00 |